168 results
Page 4 of 9
6-K
EX-1.1
z2l1zjz
13 Apr 22
Current report (foreign)
4:12pm
6-K
EX-1.1
sddahlni85sztx
31 Mar 22
Current report (foreign)
5:53pm
6-K
EX-4.1
64oo15t
29 Mar 22
Ascendis Pharma Announces Proposed Convertible Senior Notes Offering
5:01pm
6-K
EX-1.1
z9yo8doakap 3kq
29 Mar 22
Ascendis Pharma Announces Proposed Convertible Senior Notes Offering
5:01pm
6-K
EX-99.1
1ia9yedk5 xg
10 Jan 22
Current report (foreign)
8:24am
6-K
EX-99.1
z86kaleur sa9
15 Dec 21
Current report (foreign)
11:45am
S-8
jnwpcf7 j91p1w
9 Dec 21
Registration of securities for employees
12:00am
S-8
EX-23.1
0o9pf2
9 Dec 21
Registration of securities for employees
12:00am
6-K
EX-99.2
2n6o5s133xl
10 Nov 21
Current report (foreign)
4:15pm
6-K
EX-1.1
bi9ymlv8rr236 dq
7 Sep 21
Current report (foreign)
4:55pm
424B5
0fzoqexfp7 ul337
2 Sep 21
Prospectus supplement for primary offering
4:36pm
424B5
15iikm7wesihm q8l
31 Aug 21
Prospectus supplement for primary offering
5:01pm
6-K
EX-99.2
ojfnr pntuv
26 Aug 21
Current report (foreign)
9:39pm
6-K
EX-99.1
vn1 lz2uxroxx
25 Aug 21
Ascendis Pharma A/S Reports Second Quarter 2021 Financial Results
9:51pm
6-K
lj74haj7cyjvzn
6 Jul 21
Current report (foreign)
8:31am
F-3ASR
ovtmoopvznjkw81 995p
27 May 21
Automatic shelf registration (foreign)
5:23pm
F-3ASR
EX-4.4
8hre1j
27 May 21
Automatic shelf registration (foreign)
5:23pm